Stockholders’ Deficiency (Details) $ / shares in Units, $ in Thousands			3 Months Ended		9 Months Ended
	Aug. 19, 2024 USD ($) trading_day $ / shares shares	Feb. 14, 2024 USD ($) trading_day $ / shares shares	Sep. 30, 2025 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) shares	Sep. 30, 2025 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) shares	Dec. 31, 2024 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock authorized (in shares)			1,000,000,000		1,000,000,000		1,000,000,000
Common stock par value (in dollars per share) | $ / shares			$ 0.01		$ 0.01		$ 0.01
Stock repurchased (in shares)			2,026	12,821	6,901	274,692
Payments of taxes from common stock withheld | $			$ 12	$ 11	$ 28	$ 497
Issuance of common stock for restricted stock units | $	$ 15,000
Issuance of common stock in connection with settlement of Series H convertible preferred stock (in shares)	17,797,817
Share price (in dollars per share) | $ / shares	$ 840
Stock purchase agreement, trading days | trading_day	60
Private Placement
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price (in dollars per share) | $ / shares		$ 2.16
Stock purchase agreement, trading days | trading_day		60
Sale of stock, shares issued (in shares)		5,555,555
Sale of stock, consideration received | $		$ 12,000
Restricted stock units
Accumulated Other Comprehensive Income (Loss) [Line Items]
Vesting of restricted stock units (in shares)			13,695	89,119	26,193	836,259